Tobacco Cessation Field Study for Adults in Recovery - 1
NCT ID: NCT00109460
Last Updated: 2015-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
203 participants
INTERVENTIONAL
2003-03-31
2005-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identifying Optimal Smoking Cessation Intervention Components (Cessation)
NCT01116986
Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient
NCT01277250
Smoking Cessation Intervention
NCT03072511
Working Inside for Smoking Elimination
NCT01122589
Telephone Counseling for Tobacco Cessation
NCT01489579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSSOVER
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tobacco Use Disorder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Smoke at least one cigarette a day
* Be willing to sign informed consent and undergo initial assessment and follow-up
* Be willing to provide at least one collateral contact and collateral contact information
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Inflexxion, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen F Butler, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Inflexxion, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SPIRITT Family Services
La Puente, California, United States
Athol Behavioral Health Center
Athol, Massachusetts, United States
Home of New Vision
Ann Arbor, Michigan, United States
New Life Home for Recovering Women, Inc
Detroit, Michigan, United States
Brooklyn Psychiatric Centers
Brooklyn, New York, United States
North General Hospital
New York, New York, United States
Maple Leaf Counseling, Inc.
Montpelier, Vermont, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-80460-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.